Ligand Pharmaceuticals Inc SEC filings LGNYZ

Ligand Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to May 14, 2015. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Ligand Pharmaceuticals Inc SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 30, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 24, 2026 Sep 24, 2026
8-K Current report
Regulation FD disclosure
Sep 22, 2026 Sep 22, 2026
8-K/A Amended current report Sep 2, 2026 Jul 14, 2026
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
S-8 Employee stock plan registration Jul 22, 2026 —
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Regulation FD disclosure
Jul 14, 2026 Jul 14, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jun 25, 2026 Jun 25, 2026
8-K Current report
Material agreement, Other events
Jun 22, 2026 Jun 22, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 9, 2026 Jun 5, 2026
DEFA14A Additional proxy material May 18, 2026 —
8-K Current report
Material agreement
May 18, 2026 May 16, 2026
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
8-K Current report
Agreement ended
Apr 30, 2026 Apr 24, 2026
DEFA14A Additional proxy material Apr 28, 2026 —
DEFA14A Additional proxy material Apr 27, 2026 —
8-K Current report
Material agreement, Other events
Apr 27, 2026 Apr 27, 2026
ARS Annual report to shareholders Apr 21, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 21, 2026 —
DEF 14A Proxy statement Apr 21, 2026 Dec 31, 2025
S-3ASR Automatic shelf registration Feb 27, 2026 —
10-K Annual report Feb 27, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Regulation FD disclosure
Dec 18, 2025 Dec 18, 2025
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Material agreement, New debt
Sep 16, 2025 Sep 12, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Aug 14, 2025 Aug 11, 2025
8-K Current report
Material agreement, Other events
Aug 11, 2025 Aug 11, 2025
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Regulation FD disclosure
Jul 2, 2025 Jul 2, 2025
8-K Current report
Shareholder vote results
Jun 9, 2025 Jun 9, 2025
10-Q Quarterly report May 9, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Apr 22, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 22, 2025 —
DEF 14A Proxy statement Apr 22, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Apr 17, 2025 Apr 16, 2025
10-K Annual report Feb 28, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Feb 25, 2025 Feb 24, 2025
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
8-K Current report
Officer or director change
Aug 2, 2024 Aug 2, 2024
8-K Current report
Acquisition or sale of assets
Jul 17, 2024 Jul 15, 2024
8-K Current report
Material agreement, New debt
Jul 10, 2024 Jul 8, 2024
S-8 Employee stock plan registration Jul 9, 2024 —
8-K Current report
Material agreement, Regulation FD disclosure
Jul 8, 2024 Jul 8, 2024
8-K Current report
Other events
Jun 27, 2024 Jun 27, 2024
8-K Current report
Other events
Jun 18, 2024 Jun 18, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 17, 2024 Jun 14, 2024
DEFA14A Additional proxy material Jun 3, 2024 —
8-K Current report
Other events
May 30, 2024 May 29, 2024
DEFA14A Additional proxy material May 9, 2024 —
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
8-K Current report
Material agreement
May 7, 2024 May 6, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Dec 31, 2023
8-K Current report
Bylaw or fiscal year change
Apr 19, 2024 Apr 17, 2024
S-8 Employee stock plan registration Mar 1, 2024 —
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 27, 2024 Feb 27, 2024
8-K Current report
Other events
Jan 8, 2024 Jan 5, 2024
8-K Current report
Material agreement
Dec 1, 2023 Nov 29, 2023
8-K/A Amended current report
Results of operations
Nov 13, 2023 Nov 9, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
8-K Current report
Other events
Oct 18, 2023 Oct 18, 2023
8-K Current report
Material agreement, Acquisition or sale of assets
Oct 18, 2023 Oct 12, 2023
8-K Current report
Officer or director change
Sep 27, 2023 Sep 22, 2023
8-K Current report
Other events
Sep 18, 2023 Sep 18, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Shareholder vote results
Jun 9, 2023 Jun 9, 2023
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
CT ORDER Filing Apr 26, 2023 —
ARS Annual report to shareholders Apr 20, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 20, 2023 —
DEF 14A Proxy statement Apr 20, 2023 —
8-K Current report
Other events
Mar 13, 2023 Mar 13, 2023
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 22, 2023 Feb 22, 2023
8-K Current report
Officer or director change
Dec 14, 2022 Dec 13, 2022
8-K Current report
Officer or director change
Dec 5, 2022 Dec 5, 2022
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 7, 2022 Nov 7, 2022
8-K Current report
Material agreement, Acquisition or sale of assets, Officer or director change
Nov 4, 2022 Nov 1, 2022
425 Filing Oct 3, 2022 —
8-K Current report
Other events
Oct 3, 2022 Oct 3, 2022
8-K Current report
Material agreement
Sep 30, 2022 Sep 30, 2022
S-3ASR Automatic shelf registration Sep 30, 2022 —
425 Filing Aug 24, 2022 —
S-8 Employee stock plan registration Aug 10, 2022 —
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
8-K Current report
Officer or director change
Aug 2, 2022 Jul 29, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 29, 2022 Jun 29, 2022
425 Filing Jun 21, 2022 —
8-K Current report
Regulation FD disclosure
Jun 21, 2022 Jun 21, 2022
S-8 Employee stock plan registration Jun 13, 2022 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2022 Jun 10, 2022
10-Q Quarterly report May 9, 2022 Mar 31, 2022
425 Filing May 5, 2022 —
8-K Current report
Results of operations
May 4, 2022 May 4, 2022
DEFA14A Additional proxy material Apr 22, 2022 —
DEF 14A Proxy statement Apr 22, 2022 Jun 10, 2022
425 Filing Mar 24, 2022 —
8-K Current report
Material agreement
Mar 24, 2022 Mar 23, 2022
425 Filing Mar 23, 2022 —
8-K Current report
Other events
Mar 23, 2022 Mar 23, 2022
10-K Annual report Feb 28, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 17, 2022 Feb 17, 2022
8-K Current report
Officer or director change
Jan 27, 2022 Jan 26, 2022
8-K Current report
Agreement ended
Jan 14, 2022 Jan 14, 2022
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 9, 2021 Nov 9, 2021
8-K Current report
Other events
Aug 16, 2021 Aug 16, 2021
10-Q Quarterly report Aug 3, 2021 Jun 30, 2021
8-K Current report
Results of operations
Jul 29, 2021 Jul 29, 2021
8-K Current report
Other events
Jul 21, 2021 Jul 21, 2021
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Jul 14, 2021 Jul 12, 2021
8-K Current report
Shareholder vote results
Jun 7, 2021 Jun 4, 2021
DEFA14A Additional proxy material May 18, 2021 —
10-Q Quarterly report May 6, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 3, 2021 May 3, 2021
DEFA14A Additional proxy material Apr 23, 2021 —
DEF 14A Proxy statement Apr 23, 2021 Jun 4, 2021
10-K Annual report Feb 24, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 3, 2021 Feb 3, 2021
8-K Current report
Material agreement, Officer or director change
Jan 28, 2021 Jan 25, 2021
S-8 Employee stock plan registration Jan 27, 2021 —
UPLOAD Letter from the SEC Jan 13, 2021 —
CORRESP Letter to the SEC Jan 6, 2021 —
UPLOAD Letter from the SEC Dec 23, 2020 —
8-K Current report
Other events
Dec 21, 2020 Dec 18, 2020
8-K Current report
Officer or director change, Shareholder vote results
Dec 16, 2020 Dec 15, 2020
8-K/A Amended current report Dec 10, 2020 Oct 1, 2020
8-K Current report
Other events
Dec 3, 2020 Dec 2, 2020
8-K Current report
Other events
Nov 23, 2020 Nov 23, 2020
DEF 14A Proxy statement Nov 12, 2020 Dec 15, 2020
10-Q Quarterly report Nov 6, 2020 Sep 30, 2020
PRE 14A Preliminary proxy statement Oct 30, 2020 Dec 15, 2020
8-K Current report
Bylaw or fiscal year change
Oct 30, 2020 Oct 26, 2020
8-K Current report
Results of operations
Oct 30, 2020 Oct 30, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Oct 20, 2020 Oct 20, 2020
8-K Current report
Material agreement, Regulation FD disclosure
Oct 13, 2020 Oct 11, 2020
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Oct 1, 2020 Oct 1, 2020
SC TO-T/A Filing Sep 30, 2020 —
8-K Current report
Material agreement
Sep 23, 2020 Sep 21, 2020
CORRESP Letter to the SEC Sep 16, 2020 —
SC TO-T/A Filing Sep 16, 2020 —
SC TO-T/A Filing Sep 11, 2020 —
8-K Current report
Material agreement
Sep 10, 2020 Sep 8, 2020
SC TO-T Filing Aug 31, 2020 —
SC TO-C Filing Aug 11, 2020 —
SC TO-C Filing Aug 11, 2020 —
8-K Current report
Material agreement
Aug 11, 2020 Aug 10, 2020
10-Q Quarterly report Aug 7, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 3, 2020 Aug 3, 2020
CT ORDER Filing Jun 15, 2020 —
8-K Current report
Shareholder vote results
Jun 11, 2020 Jun 10, 2020
10-Q Quarterly report May 8, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 6, 2020 May 6, 2020
DEFA14A Additional proxy material Apr 24, 2020 —
DEF 14A Proxy statement Apr 24, 2020 Apr 24, 2020
8-K Current report
Material agreement
Apr 7, 2020 Apr 6, 2020
8-K Current report
Results of operations, Other events
Apr 6, 2020 Apr 6, 2020
8-K Current report
Other events
Apr 2, 2020 Apr 1, 2020
10-K Annual report Feb 27, 2020 Dec 31, 2019
8-K Current report
Material agreement, Other events
Feb 11, 2020 Feb 11, 2020
8-K Current report
Results of operations
Feb 6, 2020 Feb 6, 2020
8-K Current report
Other events
Jan 10, 2020 Jan 10, 2020
8-K Current report
Officer or director change
Dec 23, 2019 Dec 20, 2019
10-Q Quarterly report Nov 8, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 5, 2019 Nov 5, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 16, 2019 Oct 15, 2019
8-K Current report
Other events
Sep 12, 2019 Sep 11, 2019
8-K Current report
Other events
Sep 12, 2019 Aug 27, 2019
S-8 Employee stock plan registration Aug 8, 2019 —
10-Q Quarterly report Aug 8, 2019 Jun 30, 2019
8-K Current report
Results of operations
Jul 30, 2019 Jul 30, 2019
8-K Current report
Other events
Jul 24, 2019 Jul 23, 2019
8-K Current report
Other events
Jul 3, 2019 Jun 30, 2019
8-K Current report
Other events
Jun 12, 2019 Jun 12, 2019
8-K Current report
Officer or director change, Shareholder vote results
Jun 10, 2019 Jun 6, 2019
DEFA14A Additional proxy material Jun 4, 2019 —
8-K Current report
Other events
Jun 3, 2019 May 31, 2019
8-K Current report
Material agreement, Other events
May 24, 2019 May 22, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 2, 2019 May 2, 2019
DEFA14A Additional proxy material Apr 24, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LGND (Nasdaq), LGNDZ (OTC), LGNXZ (OTC), LGNYZ (OTC), LGNZZ (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
886163
Former names
LIGAND PHARMACEUTICALS (until Sep 13, 1994)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.